GlassScriptPhysician profile
Sarah T Graner
NPI 1053671552
$9,738.33
in general payments reported to CMS, 2019-2025
37 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,415 · 2020: $2,236 · 2021: $3,549 · 2022: $183 · 2023: $92.48 · 2024: $123 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,218.30 | 2019-2020 | |
| Abbott Laboratories | $1,499.77 | 2019-2023 | Infinity |
| Ucb, INC. | $691.29 | 2020-2021 | |
| Abbvie INC. | $678.26 | 2021-2025 | |
| Allergan, INC. | $567.34 | 2020-2021 | |
| Eisai INC. | $502.95 | 2020-2025 | |
| Amgen INC. | $437.21 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $433.04 | 2020-2021 | |
| Biogen, INC. | $356.17 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $304.96 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $209.39 | 2020-2021 | |
| Neurelis, INC. | $190.55 | 2020-2021 | |
| Lundbeck LLC | $179.59 | 2020-2021 | |
| Upsher-Smith Laboratories LLC | $175.19 | 2020-2021 | |
| Merz North America, INC. | $163.45 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $116.46 | 2021 | |
| Novartis Pharmaceuticals Corporation | $105.13 | 2020-2021 | |
| Lilly USA, LLC | $100.15 | 2021-2022 | |
| Medtronic, INC. | $92.83 | 2022 | |
| Jazz Pharmaceuticals INC. | $67.52 | 2020-2021 | |
| Adamas Pharmaceuticals, INC. | $65.73 | 2021 | |
| Harmony Biosciences LLC | $65.44 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $58.99 | 2020-2021 | |
| Akcea Therapeutics, INC. | $55.94 | 2020 | |
| Acorda Therapeutics, INC | $43.61 | 2021 | |
| Csl Behring | $43.17 | 2020 | |
| Merz Pharmaceuticals, LLC | $42.57 | 2022 | |
| Tanabe Pharma America, INC. | $37.94 | 2021 | |
| Emd Serono, INC. | $35.51 | 2021 | |
| Amneal Pharmaceuticals LLC | $35.06 | 2021 | |
| Catalyst Pharmaceuticals, INC. | $31.79 | 2021 | |
| Sk Life Science, INC. | $31.53 | 2021 | |
| Grifols USA, LLC | $26.72 | 2020 | |
| Alnylam Pharmaceuticals INC. | $21.22 | 2021 | |
| Livanova USA, INC. | $18.41 | 2020 | |
| Avanir Pharmaceuticals, INC. | $17.64 | 2021 | |
| Arbor Pharmaceuticals, INC. | $17.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Graner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.